These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28087270)

  • 21. Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care.
    Vita A; Deste G; Barlati S; De Peri L; Giambra A; Poli R; Keefe RS; Sacchetti E
    Schizophr Res; 2013 May; 146(1-3):217-23. PubMed ID: 23510596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revisiting the persistent negative symptoms proxy score using the Clinical Assessment Interview for Negative Symptoms.
    Li Y; Li WX; Zou YM; Yang ZY; Xie DJ; Yang Y; Lui SSY; Strauss GP; Cheung EFC; Chan RCK
    Schizophr Res; 2018 Dec; 202():248-253. PubMed ID: 29996973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
    Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Korean Version of the Clinical Assessment Interview for Negative Symptoms.
    Jang SK; Park SC; Choi KH; Yi JS; Park JK; Lee JS; Lee SH
    Psychiatry Investig; 2017 Jul; 14(4):413-419. PubMed ID: 28845167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report.
    Kim JS; Jang SK; Park SC; Yi JS; Park JK; Lee JS; Choi KH; Lee SH
    Neuropsychiatr Dis Treat; 2016; 12():1167-72. PubMed ID: 27274251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.
    Strauss GP; Gold JM
    Schizophr Bull; 2016 Nov; 42(6):1384-1394. PubMed ID: 27174556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Vayisoğlu S; Karahan S; Gürel ŞC; Yağcioğlu AEA
    Noro Psikiyatr Ars; 2024; 61(1):59-65. PubMed ID: 38496217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia.
    Rekhi G; Alphs L; Ang MS; Lee J
    Eur Neuropsychopharmacol; 2019 Dec; 29(12):1433-1441. PubMed ID: 31761524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CAINS: theoretical and practical advances in the assessment of negative symptoms in schizophrenia.
    Barch DM
    Am J Psychiatry; 2013 Feb; 170(2):133-5. PubMed ID: 23377630
    [No Abstract]   [Full Text] [Related]  

  • 30. Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders.
    Cuesta MJ; Sánchez-Torres AM; Lorente-Omeñaca R; Moreno-Izco L; Peralta V;
    Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1537-1546. PubMed ID: 32895741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Assessment Interview for Negative Symptoms (CAINS): A Systematic Review of Measurement Properties.
    Wehr S; Weigel L; Davis J; Galderisi S; Mucci A; Leucht S
    Schizophr Bull; 2024 Jul; 50(4):747-756. PubMed ID: 37951838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.
    Blanchard JJ; Kring AM; Horan WP; Gur R
    Schizophr Bull; 2011 Mar; 37(2):291-9. PubMed ID: 20861151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Negative symptoms in youths with psychosis spectrum features: complementary scales in relation to neurocognitive performance and function.
    Gur RE; March M; Calkins ME; Weittenhiller L; Wolf DH; Turetsky BI; Gur RC
    Schizophr Res; 2015 Aug; 166(1-3):322-7. PubMed ID: 26093946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).
    Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
    J Psychiatr Res; 2016 Sep; 80():87-92. PubMed ID: 27318892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale.
    Keefe RS; Davis VG; Spagnola NB; Hilt D; Dgetluck N; Ruse S; Patterson TD; Narasimhan M; Harvey PD
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):176-84. PubMed ID: 25028065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function.
    Kleinman L; Lieberman J; Dube S; Mohs R; Zhao Y; Kinon B; Carpenter W; Harvey PD; Green MF; Keefe RS; Frank L; Bowman L; Revicki DA
    Schizophr Res; 2009 Feb; 107(2-3):275-85. PubMed ID: 19013769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factorial Structure of the Serbian Version of the Clinical Assessment Interview for Negative Symptoms - Evidence for Three Factors of Negative Symptoms.
    Ristić I; Jerotić S; Zebić M; Savić B; Vuković V; Russo M; Voskresenski T; Jovanović N; Marić NP
    Front Psychol; 2020; 11():570356. PubMed ID: 33192856
    [No Abstract]   [Full Text] [Related]  

  • 38. A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.
    Mueser KT; Sayers SL; Schooler NR; Mance RM; Haas GL
    Am J Psychiatry; 1994 Oct; 151(10):1453-62. PubMed ID: 7916540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concordance of self- and observer-rated motivation and pleasure in patients with negative symptoms and healthy controls.
    Engel M; Lincoln TM
    Psychiatry Res; 2017 Jan; 247():1-5. PubMed ID: 27863311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia.
    Savill M; Orfanos S; Reininghaus U; Wykes T; Bentall R; Priebe S
    Schizophr Res; 2016 Oct; 176(2-3):387-391. PubMed ID: 27328889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.